Solvonis Therapeutics completes acquisition of Awakn Life Sciences

  • Solvonis Therapeutics PLC (LSEVNS) has now completed its acquisition of Awakn Life Sciences. The transaction covers multiple assets, including SVNS-001, a Phase 3 therapy for Alcohol Use Disorder.